PRF1 and neoplasm: CD8 T cells, as the primary anti-tumor cells in tumor infiltrating lymphocytes, could realize the releasing of perforin and granule enzyme B via Fas / FasL pathway through cell contact, or destroy targeted cells via the release of IFN—γ and TNF cytokines [3].